| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.21 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |